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Contrast Injection Under Resting Flow 
Conditions (798-1) • 280A 
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Identification of Patients With Restenosis After 
Percutaneous Transluminal Coronaty 
Angioplasty (903-69) .54A 
Extracorporeal circulation 
Emergent Percutaneous Cardiopulmonaty Bypass 
Support Following Cardiac Arrest (952-12). 
293A 
Prophylactic Percutaneous CardiopuImonaty Bypass 
Versus Intra-Aortic Balloon Pump Support for 
High Risk Angioplasty (967-7). 349A 
Fatty acids 
Comparison of Iodine-I 23 Methylhexadecanoic 
Acid Imaging Versus Exercise-Redistribution 
SPEer Tl201 With Rest-Reinjection to Assess 
Myocardial Viability After Infarction (765-5) • 
203A 
Ischemic "Preconditioning" by Repeated Coronaty 
Thrombus Formation Is Associated With 
Favorable Alterations in Carnitine-Linked 
Metabolism in the Heart (916-66) • ll8A 
Noninvasive Detection of Cardiac Rejection - Low 
Dose 1-123 Phenylpentadecanoic Acid 
Parametric Metabolic Imaging (724-3) • 82A 
Fetal cardiology 
Preload Reserve of the Fetal Lamb Heart (823-6) • 
343A 
The Fetus With Hypertrophic Cardiomyopathy 
Related to Maternal Diabetes: A Pre and 
Postnatal Analysis of the Associated Factors 
(823-4) • 342A 
Fibrinolytic agents 
Causes of Death After Thrombolytic Therapy in 
Acute Myocardial Infarction (752-6). 154A 
Early Patency and Dose Response Relationship of 
Bolus Alteplase in Acute Myocardial Infarction 
(794-2) • 275A 
Lack of Influence of Pretreatment Anti-Streptokinase 
Antibody on Early Patency Achieved by 
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Anistreplase and Streptokinase (931-93) • 180A 
Thrombolysis With Saruplase: Pharmacokinetics and 
Conversion to Urokinase-1Ype Plasminogen 
Activator in Acute Myocardial Infarction (923-
52) .131A 
Tissue Plasminogen Activator is Avidly Metabolized 
in Macrophages by the Mannose Fucose 
Receptor (837-3) • 392A 
Fish oils 
Coconut Oil and Fish Oil Accelerate Rabbit Graft 
Coronary Atherosclerosis (827-6). 349A 
Dietary Fish Oil Reduces Infarct Size in Rats 
(916-60). ll6A 
Fish Oil Attenuates the Vasoconstrictor Response to 
Angiotensin and Not Alpha-Adrenergic 
Stimulation in Man (771-5). 212A 
Follow-up studies 
Clinical Outcome of Patients With Rest Angina and 
Multivessel Disease Undergoing Culprit vs. 
Multivessel PTCA, and the Influence of 
Complete RevascuIarization (704-4) • 23A 
Clinical Results of Heart Thmsplantation With Older 
Donors (953-1). 294A 
Follow-Up Data After Myocardial Revasculatization 
by Using Both Internal Mammaty Arteries and 
the Inferior Epigastric Artery (756-4) • 160A 
Immediate and Late Results of Percutaneous Mitral 
Balloon Valvuloplasty Using Inoue and Double 
Balloon Methods: 1 Year Follow-Up (745-5) • 
143A 
Specific Sequelae After Fontan Operation at Mid and 
Long-Term Follow-Up (713-5). 37A 
Free radicals 
Deferoxamine Prevents Dysfunction of Canine 
Coronary Endothelium Following Brief Ischemia 
(936-49) • 191A 
Oxygen Free Radicals Mediate Cardiac Myocyte 
Membrane Damage and CK-MB Release During 
Episodes of Thmsient Myocardial Ischaemia 
(905-105).61A 
Pyruvate Reduces Free-Radical Generation 
Following Myocardial Ischemia and Reperfusion 
in Isolated Rat Hearts (904-91) • 58A 
Role of Lipid Peroxidation in Acute Adriamicin 
1bxicity (926-15). 135A 
G proteins 
~ Muscarinic Receptors Are Coupled to a Positive 
Inotropic Response in Human Ventricular 
Myocardium (826-2) • 346A 
Gene expression 
Analysis of Parameters Affecting Gene Expression 
Following In Vivo Myocardial Thmsfection 
(709-6) • 31A 
Angiographic and Morphologic Analysis of 
Atherosclerotic Arteries Exposed to a Site•
Specific Percutaneous Gene Thmsfer Procedure 
Post-Angioplasty (775-6). 218A 
Human Growth Hormone Production After In Vivo 
Arterial Gene Transfer in Rabbit Artery: Foreign 
Protein Synthesis Following Liposome Mediated 
Transfection (737-5) • 102A 
In Vivo Gene Thmsfer Into the Arterial Wall Without 
a Transfection Vehicle (837-1). 392A 
Influence of Vascular Proliferation on In Vivo Gene 
Transfection of Canine Arterial Walls (737-6) • 
103A 
Reversible Alterations in Cardiac Gene Expression in 
a Patient With Dilated Cardiomyopathy and 
Hypothyroidism: Serial Measures by 
Quantitative Polymerase Chain Reaction (792-5) 
.272A 
The Human Myoglobin Promoter Directs Chamber•
Specific and Transmurally Heterogeneous 
Thmscription in Hearts of Transgenic Mice 
(737-2) • l02A 
Genetic techniques 
Human Growth Hormone Production After In Vivo 
Arterial Gene Thmsfer in Rabbit Artery: Foreign 
Protein Synthesis Following Liposome Mediated 
Transfection (737-5) • 102A 
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In Vitro Gene Transfer Into Vascular Smooth Muscle 
Cells by Particle Bombardment (910-53). 7lA 
In Vivo Gene Transfer Into the Arterial WaIl Without 
a Thmsfection Vehicle (837-1) • 392A 
Genetics 
Common Fonns of Familial 
Hypoalpbalipoproteinemia in Patients With 
Premature Coronary Artery Disease (750-3) • 
1SOA 
Genetic Screening for Risk of Coronary Artery 
Disease: Prospectus (750-1). 150A 
Identification of Two Mutations in the Beta Myosin 
Heavy Chain Gene in Hypertrophic 
Cardiomyopathy: A 403 Arg-+GIn Mutation 
Associated With a High Incidence of Sudden 
Death and a 908 Leu-+ Val Mutation in a Family 
With Infrequent Sudden Death (792-1) • 271A 
Pattern of Inheritance of Familial Dilated 
Cardiomyopathy (917-98) • 120A 
Glucose 
Increasing Glycolytic Flux During Ischemia Limits 
Tissue Damage and Enhances Functional 
Recovery With Reperfusion (818-6) • 335A 
Growth factors 
Augmentation of Syuthesis of Plasminogen Activator 
Inhibitor 1YPe-1 (PAl-I) by Insulin-Like Growth 
Factor 1YPe-1 (lGF-1) in Endothelial Cells 
(837-5). 393A 
Comparison of the Distribution of Laminin and 
Fibronectin in the Developing Rat Heart (910-49) 
.70A 
Evidence That Antihypertensive Agents Lessen 
Ventricular Hypertrophy by Inhibiting Cardiac 
Expression of Insulin-Like Growth Factor-I (726-
2).85A 
Expression of Transforming Growth Factor Beta 1 in 
Human Atherectomy Specimens From Primary 
and Restenotic Coronary Artery Lesions (813-4) 
• 329A 
Interleukin-6: A Marlter for Coronary Artery Disease 
(943-93) • 240A 
Heart block 
Isolated Long PR Interval as Only Indication of 
Permanent DDD Pacing (907-86). 66A 
Thrombolytic Therapy in the Treatment of Complete 
Heart Block Complicating Acute Myocardial 
Infarction (930-62) • 177 A 
Transvenous DDD Pacing in the First Decade of Life 
(902-33) • 51A 
Heart catheterization 
Long-Term Follow-Up of Thanscatheter Closure of 
PDA (705-5) • 25A 
Mobile Cardiac Catheterization: Comparison With 
Outpatient and Inpatient Catheterization at 
Tertiary Facilities (716-5). 42A 
Safety of Cardiac Catheterization via Aorto-Femoral 
Grafts (966-18) .319A 
Transcatheter Closure of Atrial Septal Defects in 
Adults With Piatypnea-Orthodeoxia Syndrome 
(803-5) • 289A 
Use of the "Smart Needle" for Internal Jugular and 
Subclavian Vein Cannulation (732-6) • 95A 
Heart conduction system 
Aging Effect on Circadian Variablilty of Cardiac 
Vagal Activity (761-6) • 168A 
Induction of Manifest. Concealed and Latent Pre•
Excitation in the Normal Dog Heart (934-90) • 
186A 
Heart defects, congenital 
Anatomic Repair of 1i'ansposition of the Great 
Arteries (TGA) in Neonates (713-1). 36A 
Comparison Between Transesophagea1 and 
Thansthoracic Echocardiographic Assessment of 
Shunting After ASD Device Occlusion (748-2) • 
147A 
Comparison of Stcnt Implantation With Balloon 
Dilation for Maintenance of Ductus Arteriosus 
Patency (705-6) • 25A 
Congenital Heart Disease After Pediatrics: A 
Quantitative Model of the Challenge-Patients 
and Providers (970-37). 355A 
Congenital Heart Disease: Prevalence and Outcome. 
1980-89 (970-38). 355A 
Effects of Different Modes of Ventilation on 
Diastolic Filling After Arterial Switch Operation 
(902 -34) • 52A 
Effects of Homograft Blood 1YPe and Anatomic 
1YPe on Stenosis. Insufficiency and Calcification 
in the Pulmonary Position in 39 Consecutive 
Children (940-1). 231A 
Evaluation of Thtal Cavopulmonary Connection in 
Modified Fontan Operation From Hepatic 
Circulation (940-29) • 232A 
Hemodynamic Effects of Closure of the Adjustable 
Interatrial Communication After the Fontan 
Procedure (776-1). 218A 
Imaging Pulmonary Venous Pathway Obstruction in 
Patients After the Modified Fontan Procedure 
(748-5). 148A 
Incidence and Risk Factors of Inducible Ventricular 
Tachycardia After Atrial Switch (902-27) • 50A 
Influence of Serum Lipoprotein(a) Level on the 
Coronary Vasomotor Response of Acetylcholine 
(904-62) • 57 A 
Initial Studies Using the New Thmscatheter 
Gianturco Vascular Occlusion Device (705-2) • 
24A 
Myocardial Perfusion. Function and Exercise 
Tolerance After the Arterial Switch Operation 
(776-6) • 2l9A 
Pregnancy in Cyanotic Congenital Heart Disease: 
Maternal Complications and Factors Influencing 
Successful Foetal Outcome (803-2). 288A 
Regional Ventricular WaIl Motion Abnormalities in 
Tricuspid Atresia After the Fontan Procedure 
(940-3) • 232A 
Systemic Ventricular Outflow Obstruction 
Progresses After the Fontan Operation (776-4) • 
219A 
Systemic Ventricular Size and Performance Before 
and After Bidirectional Cavopulmonary 
Anastomosis (BCPA) (776-5). 219A 
The Bidirectional Glenn Shunt Staged 
Reconstruction for the Functional Single 
Ventricle (713-2) • 36A 
The Etiology of Cardiovascular Malformations: A 
Ten-Year Population-Based Study (970-39) • 
355A 
The Natural History of Arrhythmias in Ebstein's 
Anomaly (793-3). 273A 
The Role of Transesophageal Echocardiography 
Following Repair of Thtal Anomalous 
Pulmonary Venous Connection (940-2). 231A 
Total Correction of Nonconfluent Pulmonary 
Arteries (776-2). 218A 
Ventriculo-Coronary Arterial Connections in 
Pulmonary Atresia With Intact Ventricular 
Septum: Influences Upon Ventricular 
Performance and Clinical Course (776-3). 219A 
Heart disease 
Adverse Proguostic Impact of Unstable Angina 
Without Antecedent Symptoms (722-6) • 80A 
Determinants of Lethal Outcome in Unstable Angina 
(722-4).80A 
Role of Lipid Peroxidation in Acute Adriamicin 
Toxicity (926-15). 135A 
Heart failure, congestive 
Acute Dynamic Cardiomyoplasty Augments Left 
Ventricular Systolic Function (969-32) • 354A 
Acute Dynamic Cardiomyoplasty Impairs Left 
Ventricular Diastolic Function (969-29) • 353A 
Acute Effects of the Angiotensin IT Antagonist, DUP 
753. in Heart Failure (747-2) • 146A 
Age Related Changes in Beta-1 and Beta-2 
Adrenergic Receptors and Adenylate Cyclase 
Stimulation in Nonfailing and Failing Human 
Hearts (937-57) • 194A 
Amelioration of the Heart Failure With Left 
Ventricular Assist System Support (950-57) • 
254A 
SUBJECT INDEX 447A 
Beta-Blockade With Carvedilol Selectively Lowers 
Cardiac Adrenergic Drive in the Failing Human 
Heart (747-4). 146A 
Beta-Blocker Related Improvement in Submaxinta1 
Exercise Thlerance in Heart Failure From 
Idiopathic Dilated Cardiomyopathy (IDC) (747-
5) .146A 
Characterization of the Proanhythmic Effects of Oral 
Milrinone in Severe Heart Failure: The 
PROMISE Study (784-4). 260A 
Circulating Thmor Necrosis Factor and Endothelial•
Derived Relaxing Factor in Severe Heart Failure 
(768-6).207A 
Clinical and Prognostic Importance of Serum 
Magnesium Concentration in Patients With 
Severe Chronic Heart Failure: The PROMISE 
Study (950-55) • 254A 
Coenzyme QlO as an Adjunctive in Treatment of 
Congestive Heart Failure (774-6). 216A 
Comparative Effects of the Vasodilators Flosequinan 
and Hydralazine on the Contractile Function of 
Isolated Human Cardiac Muscle (950-51) • 253A 
Contrasting Efficacy and Safety of Low Versus High 
Degree of Phosphodiesterase Inhibition in Mild 
Heart Failure (784-5) • 260A 
Creatine Kinase Levels May Be a Determinant of 
Prognosis After Cardiomyoplasty - Preliminary 
Results (734-6). 98A 
Development of a Third Heart Sound in Heart Failure 
is Associated With Rapid Deceleration of Early 
Mitral Inflow (926-16). 135A 
Diverse Metabolic Response of Cardiac Versus 
Skeletal Muscle in Experimental Heart Failure 
(965-54). 317A 
Effect of Captopril and Digoxin on Quality of Life 
and Clinical Symptoms in Patients With 
Coronary Artery Disease and Mild Heart Failure 
(784-3) • 260A 
Effect of Intravenous Magnesium on Ventricular 
Arrhythmia in Patients With Heart Failure (950-
54).253A 
Effects of Propranolol on Cardiac Neurochemical 
Markers in a Canine Model of Heart Failure 
(950-48) • 252A 
Effects of Renal Endopeptidase Inhibition on Sodium 
Excretion and Renal Hemodynamics in Heart 
Failure (747-3) • 146A 
Elevated Endothelium-Derived Relaxing Factor 
Assayed Directly in Sera From Heart Failure 
Patients (768-5) • 207 A 
Endothelin, Angiotensin IT and Coagulation in Heart 
Failure (965-22) • 316A 
Exercise Training Improves Ventilatory 
Abnormalities in Chronic Heart Failure (757-6) • 
162A 
Failure of Low But Not High Dose Chronic EnalapriJ 
Therapy to Suppress Serum Angiotensin 
Converting Enzyme (ACE) Activity in Heart 
Failure (747-1) • 145A 
Forearm Vascular Responsiveness to AJpha-2 
Adrenoceptor Stimulation in Patients With 
Congestive Heart Failure (965-24). 316A 
Heart Rate Variability in Clinical Heart Failure: 
Persistence of a Circadian Pattern (911-57) 
.73A 
Hemodynamic Effects of Long-Term Treatment 
With Coenzyme QlO in Patients With 
Congestive Heart Failure (950-53) • 253A 
Hypokalemia and Ventricular Dilatation Have 
Synergistic Effects on Inducible Ventricular 
Arrhythmias in the Isolated Heart (934-117) • 
186A 
Important Contrasting Actions of Brain Natriuretic 
Peptide Upon the Cardiovascular and Renal 
System in Normals Versus Congestive Heart 
Failure (910-48) • 70A 
Improvement in Large Artery Function Following 
Acute Diuresis in Patients With Severe Chronic 
Heart Failure (950-49) • 252A 
Increased Alveolar-Capillary Membrane Resistance 
448A SUBrncr INDEX 
to Gas Exchange in Chronic Congestive Heart 
Failure (757-5). 161A 
Increased Beta-I Receptor Expression at mRNA 
Level in Dilated Cardiomyopathy (792-6). 273A 
Increased HLA-Ciass I and II Antigen Expression in 
Endomyocardial Biopsies of Patients With 
Clinical Suspected Myocarditis and Dilated 
Cardiomyopathy (911-25). 72A 
Is There Sex After Heart Failure? Report of a 
Prospective Study of Sexual Desire and 
Activity in Patients With Advanced Symptoms 
&ro11cd in the PROMISE 'llial (911-56) 
.73A 
Long-Tenn Effects of Enalapril on NYHA 
Functional Class in Patients With Left 
Ventricular Dysfunction (774-2) • 21SA 
Mechanical Restitution Patterns Predict Transition 
From Stable Left Ventricular Hypertrophy to 
Decompensated Failure (965-53). 317A 
Molsidominc in Patients Thlerant to Isosorbide 
Dinitrate (923-45). 130A 
Multicenter, Double-Blind, Placebo-Controlled 
Randomized Withdrawal Trial of the Efficacy 
and Safety of Digoxin in Patients With Mild to 
Moderate Chronic Heart Failure Not 'l1'eated 
With Converting Enzyme Inhibitors (784-1) • 
259A 
Multicenter Randomized Trial of Epoprostenol in 
Patients With Severe Heart Failure (774-5) • 
216A 
Nitroglycerin and Endothelium-Dependent 
Vasodilation in Patients With Congestive Heart 
Failure (768-3) • 2fJ7 A 
Positive Inotropic Actions of Vasodilator Drugs on 
Mammalian Myocardium: Implications for the 
Development of New Drugs for Heart Failure 
(950-50) • 252A 
Positive Inotropic Effects of Angiotensin II in 
Human Atrial Muscle Preparations Under 
Physiological Conditions (937-56) • 194A 
Post-Exercise Recovery of Phosphocreatine as an 
Index of Oxidative Capacity in Patients With 
Heart Failure (757-2). 161A 
Prognostic Paradox of Increased I-Year Mortality in 
Small Enzymatic Non-Q-Wave Myocardial 
Infarction Complicated by Heart Failure (763 -6) 
·200A 
Prostaglandins Specifically Attenuate Endothelium•
Dependent Vasodilation in Patients With 
Congestive Heart Failure (965-23) • 316A 
Randomized. Double-Blind, Placebo-Controlled, 
Withdrawal Study of Digoxin in Patients With 
Chronic Heart Failure 'l1'eated With Converting•
Enzyme Inhibitors (784-2) • 260A 
Relationship Between Mitral Annulus Motion and 
Mitral Regurgitation in Congestive Heart Failure 
(755-6) • IS9A 
Response of Plasma Norepinephrine to Long-Tenn 
Administration of Enalapril or Hydralazine•
Isosorbide Dinitrate in Heart Failure: V -HeFT II 
(774-4).216A 
Reversible Alterations in Cardiac Gene Expression in 
a Patient With Dilated Cardiomyopathy and 
Hypothyroidism: Serial Measures by 
Quantitative Polymerase Chain Reaction (792-5) 
.272A 
Safest Antiarrhythmic Drug in Advanced Heart 
Failure Depends on Heart Failure Etiology 
(721-4).78A 
Short-Term Effects Following Withdrawal From 
Enaiapril in Patients With Heart Failure (774-3) • 
216A 
Skeletal Muscle Phosphate Metabolism 
Abnormalities in Heart Failure Are Closely 
Related to Exercise Capacity But Not to 
Ventricular Function (778-2) • 221A 
Spontaneous Ventricular llIchycardias in Dogs With 
Chronic Heart Failure: Relation to Plasma 
Norepinephrine Concentration (721-6). 79A 
Stress-Induced Changes in Foreann Vascular 
Dynamics in Heart Failure: Distinction Between 
Ischemic and Dilated Cardiomyopathy (965-25) 
·316A 
Studies of Left Ventricular Dysfunction (SOLVO): 
Subgroup Results (774-1) • 21SA 
Sudden Death in Advanced Heart Failure: Incidence 
During Nocturnal Versus Daylight Hours (911-
58).73A 
Systolic Dysfunction and Decreased Availability of 
Activator Calcium in Hamsters With End-Stage 
Heart Failure (853-1) .IA 
The 6-Minute Walk Test: Useful in Mild Heart 
Failure? (911-54). 72A 
Therapeutic Response Measured by the Minnesota 
Living With Heart Failure Questionnaire (911-
55).72A 
Thlerability of Enalapril by Patients With Left 
Ventricular Dysfunction (923-47) • l30A 
Which Patients With Chronic Heart Failure Are Most 
Likely to Show Hemodynamic and Functional 
Improvement Following Long-Term Beta•
Blockade? (822-3). 34IA 
Heart function tests 
Cardiovascular Effects of Growth Hormone (923-54) 
.l32A 
Early Diastolic Driving Force: A New Index for 
Separating Relaxation From Compliance 
Abnormalities (780-6) • 22SA 
Revascu1arization Outcome Predicted by Regional 
Left Ventricular Response to Nitroglycerin: Use 
of Quantitative 3-D Wall Motion Analysis and 
Tomographic Ventriculography (922-43) • 128A 
The Timing of Changes in Left Ventricular Area by 
Echocardiography Derived From a Real-Time 
Automatic Border Detection Algorithm: 
Comparison With Cineventriculography (785-1 ) 
• 261A 
Heart rate 
A New Technique for Simultaneously Monitoring 
Gait and Ambulatory Eoo: Assessing Effects of 
Walking on Heart Rate and ECG (978-87) • 
370A 
Contractile Response to Increased Heart Rate in 
Dilated Cardiomyopathy - Influence of 
Isoproterenol (834-5) • 388A 
Cycle Length Dependence of Heart Rate Variability 
(761-5).167A 
Differential Effects of Right and Left Unilateral ECT 
on Heart Rate (966-14). 3l8A 
Does Chronotropic Response During Early 
Submaxial Exercise Identify Patients With 
Chronotropic Incompetence at Maximal 
Exercise? (733-3) • 96B 
Heart Rate Variability: Focus on Defined 
Cycle Lengths (761-1) .166A 
Heart Rate Variability in Clinical Heart 
Failure: Persistence of a Circadian Pattern (911-
57)·73A 
Relationship Between Heart Rate During 
Daily Activity and During Exercise in Patients 
With Atrial Fibril1ation (979-76). 372A 
Short-Term &drest Deconditioning Causes a 
Loss of Complex Heart Rate Variability (979-44) 
.371A 
Significance of Post-Exercise Systolic Blood 
Pressure to Heart Rate Ratio in the Diagnosis of 
Coronary Artery Disease (733-6) • 97 A 
Survival Post-Sudden Cardiac Death: 
Predictive Value of Heart Rate Variability 
Versus Inducibility (761-2). 167A 
Heart septal defects 
Detection of Different 'JYpes of Atrial Septal 
Defects by Tnmsesophageal Echocardiography 
(932-95). 180A 
Diagnosis of Patent Foramen Ovale by 
Transesophageal Contrast Echocardiography -
Interlaboratory Comparative Study (710-6) • 
33A 
Three-Dimensional Reconstruction of 
Ventricular Septal Defects: In Vivo Feasibility 
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and Validation Studies (748-1). 147A 
Tnmscatheter Closure of Atrial Septal Defects in 
Adults With Platypnea-Ortbodeoxia Syndrome 
(803-5).289A 
Heart surgery 
A New 8MM Matrix Probe Suitable for Providing 
Simultaneous Biplane Transesophageal 
Visualization in Pediatric and Adult Patients 
(941-38). 235A 
An Aggressive Surgical Approach for Patients With 
"Inoperable" Ischemic Heart Disease (734-3) • 
97A 
Anatomic Repair of Transposition of the Great 
Arteries (TGA) in Neonates (713-1). 36A 
Continuous Measurement of Cerebral Oxygen 
Saturation During Deep Hypothermic 
Circulatory Arrest (713-6). 37A 
Cost of Admission to Repair Congenital Heart 
Disease (CHO) Can Be Predicted (966-30) • 
39SA 
Does the Modified Blalock-Taussig Shunt Provide 
Long-Term Palliation? (940-28). 232A 
Effects of Homograft Blood 'JYpe and Anatomic 
'JYpe on Stenosis, Insufficiency and Calcification 
in the Pulmonary Position in 39 Consecutive 
Children (940-1) • 231A 
Evaluation of Thtal Cavopulmonary Connection in 
Modified Fontan Operation From Hepatic 
Circulation (940-29) • 232A 
Hemodynamic Effects of Closure of the Adjustable 
Interatrial Communication After the Fontan 
Procedure (776-1). 218A 
Impact of Intraoperative Echo in Open Heart 
Surgery: A Study of 1630 Consecutive Cases 
Over 8 Years (903-73). SSA 
Is There a Role for Surgical Ablation of Ventricular 
Tachycardia in the Era of the Implantable 
Defibrillator? (914-36). 113A 
Long-Term Results After Minale' s Annuloplasty of 
the Tricuspid Valve (725-5) • 84A 
Modified Ultrafiltration Improves Hemodynamics 
After Cardiopulmonary Bypass in Children (713-
3).37A 
Morphological Findings at Reoperation After Repair 
of Rheumatic Mitral Regurgitation: Mechanisms 
of Failure (725-3) • 84A 
Operative Risk Assessment Using Bayesian Theory: 
Current Standards Based on 21,777 Adult 
Cardiac Surgery Patients Compared With 12,614 
Historical Control (734-2). 97A 
Reconstructive Surgery for Left Ventricular Anterior 
Aneurysm: Early Effects on Hemodynamics and 
Regional Wall Motion (914-37) • 113A 
Systemic Ventricular Outflow Obstruction 
Progresses After the Fontan Operation (776-4) • 
219A 
Systemic Ventricular Size and Performance Before 
and After Bidirectional Cavopulmonary 
Anastomosis (BCPA) (776-5). 219A 
The Bidirectional Glenn Shunt: Staged 
Reconstruction for the Functional Single 
Ventricle (713-2). 36A 
The Damus-Stansel-Kaye Procedure: Current 
Indications and Results (940-27) • 232A 
The Effects of Hypothermia on the Signal Averaged 
Electrocardiogram (919-113). 124A 
The Results of Reoperation on Prosthetic Valves 
(725-6) • 8SA 
Heart valve prostbesis 
Effect of Valve Size and Position of Normally 
Functioning St. Jude Medical and Medtronic•
Hall Prostheses on Degree of Intravascular 
Hemolysis (969-35) • 354A 
Fixation of the Mitral Annulus by Rigid or Flexible 
Ring Annuloplasty Does Not Impair Global LV 
Systolic Function or Energetics in the Conscious 
Closed Chest Dog (975-108). 36SA 
Hemodynamic Performance of the Carpentier•
Edwards Supra-Annular Aortic Prosthesis: A 
Doppler-Echocardiographic Study at Six Months 
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Postimplant at Rest and Exercise (954-39) • 
297A 
Is Prophylaxis for Infective Endocarditis Really 
Necessary During Transesophageal 
Echocardiography in Patients With Prosthetic 
Valves? (90342) .S4A 
Management and Outcome of Patients With 
Prosthetic Valvular Thrombosis Diagnosed by 
Transesophageal Echocardiography (714-6) • 
39A 
Mitral Annuloplasty Alters Left Ventricular 
Relaxation in the Conscious, Closed Chest Dog 
(780-5) • 225A 
Significance of Doppler Echocardiographic Peak 
Valve Gradients of Greater Than 50 mrnHg in 
Otherwise Normal St. Jude Aortic Valve 
Prostheses (SJAV) (932-102). 182A 
Heart valves 
Morphological F'mdings at Reoperation After Repair 
of Rhewnatic Mitral Regurgitation: Mechanisms 
of Failure (725-3) .84A 
Pulmonary Autograft for Aortic Valve Disease: Late 
Results (725-2). 84A 
Hemodynamics 
Cardiac Function and Structure in Elderly Patients 
With Isolated Systolic Hypertension (938-17) • 
196A 
Cardiopulmonary Dynamics With EKG Gated 
Ventilation (935-82). 189A 
Determination of Left Ventricular Ejection Time 
From the Radial Pulse (912-17). 74A 
Does Ejection Fraction Predict the Likelihood of 
Ventricular Tachycardia Suppression as Well as 
Invasive Hemodynamic Measurements? (777-3) 
• 220A 
Feasibility of Generating Hemodynamic Pressure 
Curves From Doppler Echocardiographic Signals 
(701-6) • 19A 
Hemodynamic Effects of Long-Tenn Treatment 
With Coenzyme QIO in Patients With 
Congestive Heart Failure (950·53) • 253A 
Hemodynamic Effects of Ventricular Contraction 
Sequence by AV Junctional Pacing in Patients 
With SSS (907-85). 66A 
Hemodynamic Parameters 12-Hours After Onset of 
Cardiogenic Shock Can Predict Survival (974-
99). 362A 
Hemodynamics, Renal Function and Allograft 
Coronary Disease in Cardiac 1i'ansplant Patients 
lnununosuppressed With FK-S06 (766-2). 203A 
Isolated Long PR Interval as Only Indication of 
Pennanent DOD Pacing (907-86). 66A 
Modified Ultrafiltration hnproves Hemodynamics 
After Cardiopulmonary Bypass in Children (713-
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